Table 1.

Study inclusion (A) and exclusion (B) criteria.

(A) Inclusion criteria
Age	>50 years
Active subfoveal CNV (classic or occult)
Anti-VEGF therapy monthly (minimum of 2 injections)
Treatment resistance to monthly anti-VEGF therapy
BCVA	20/30-20/800
PDT or IVTA more than 6 months before dual therapy
More than 3 months of follow-up
(B) Exclusion criteria
Glaucoma or cup-to-disc ratio >0.8
History of IOP elevation (>21 mmHg or >10 mmHg from baseline) on prior intraocular, periocular, topical or systemic steroid treatment
Elevated IOP >21 mmHg from any cause with or without topical therapy
History of glaucoma surgery (glaucoma tube or trabeculectomy) for any cause
CNV from condition(s) other than nvAMD
Diabetic retinopathy
Retinal vein occlusion
Active ocular infection at the time of treatment visit
Aphakia or pseudophakia with ACIOL or scleral fixated IOL